Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate
the Efficacy and Safety of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal
Spray 100mcg for 6 Weeks in Adult and Adolescent Subjects 12 years of Age and Older with
Perennial Allergic Rhinitis (PAR)

Inclusion Criteria:

- Diagnosis of perennial allergic rhinitis (PAR).

- Must comply with study procedures and be literate.

Exclusion Criteria:

- Significant concomitant medical conditions.

- Use of corticosteroids.

- Use of allergy and other identified medications during the study.

- Current tobacco use or tobacco use within the past year.

- Exposure to an investigational study drug within the past 12 months.

- Clinically significant abnormal electrocardiograms (ECG) or laboratory abnormality.